Paragon Biosciences Launches a Facility for the Advancement of QuantX Medical Imaging AI System Diagnosing Breast Cancer

Shots:

• Paragon’s facility, Qlarity Imaging will lead the expansion of diagnostic applications of QuantX, with the additional ability of image modalities and medical conditions, improving patient care by advancing breast cancer diagnosis system in radiology
• The clinical study results assessing QuantX demonstrated a 39% reduction in missed breast cancers without a reduction in specificity and 20% overall diagnostic improvement
• QuantX is a computer-aided breast cancer diagnosis software for radiology and is the first FDA cleared AI breast cancer diagnostic tool

Click here to read full press release/ article | Ref: Paragon Biosciences | Image:Paragon Biosciences